Mechanistically, abnormal expression of SRPK1 regulates multiple signaling pathways, such as the PI3K/AKT,11 transforming growth factor-beta (TGF-β),12 and mitogen-activated protein kinase (MAPK)13 pathways in different tumor types. This evidence concerns the gene AKT1 and neoplasm.